Sanofi has kicked off 2026 with a strong first-quarter performance, reporting revenues of over €10.5 billion, a 13.6% increase at... Read more
Category: Uncategorized
English Version Strong Swiss franc masks Roche’s underlying growth in Q1 2026 results
Roche has reported its first-quarter revenues for 2026, revealing a 5% decline in reported sales to CHF 14.77 billion. However,... Read more
Unauthorised listing of UK Biobank research data discovered online
UK Biobank has reported a significant security lapse following the discovery of "de-identified" records from 500,000 participants listed for sale... Read more
Oral semaglutide demonstrates efficacy for pediatric type 2 diabetes treatment
Novo Nordisk has announced positive results from its Phase 3a PIONEER TEENS clinical trial, which examined the impact of oral... Read more
Servier finalizes acquisition of Day One Biopharmaceuticals to bolster oncology portfolio
Servier, a global independent pharmaceutical group, has concluded its tender offer for Day One Biopharmaceuticals, acquiring all outstanding common stock... Read more
Ray Therapeutics secures $125m to advance optogenetic vision therapies
Ray Therapeutics has successfully raised $125 million in an oversubscribed Series B funding round. Led by Janus Henderson Investors and... Read more
Expanded access to type 1 diabetes delay therapy for toddlers
The US Food and Drug Administration (FDA) has officially authorized the use of Tzield (teplizumab-mzwv) to postpone the onset of... Read more
Policy Gridlock: US Government to Shoulder GLP-1 Costs as Insurers Opt Out of Pilot
The Centers for Medicare & Medicaid Services (CMS) hit a significant roadblock in its obesity treatment strategy. Due to a... Read more
AbbVie’s Strategic Milestone: $1.4B Investment in AI-Integrated Manufacturing in North Carolina
AbbVie announced a landmark $1.4 billion investment to establish a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. This project... Read more









